Eurofins Genomics is a brand that specializes in biomarker discovery through DNA and RNA sequencing. Biomarkers, which are specific DNA or RNA sequences, play a crucial role in disease diagnostics and therapeutic targeting. By using state-of-the-art technologies like next-generation sequencing (NGS) and microarrays, Eurofins Genomics offers a wide range of products and services for genetic biomarker discovery.

These include whole genome sequencing, low pass whole genome sequencing, and whole exome sequencing, along with gene panels and transcriptome analysis. The company also provides genetic biomarker discovery through microarrays, including genome-wide genotyping microarrays and gene expression microarrays. Additionally, Eurofins Genomics specializes in epigenetic biomarker discovery through techniques such as whole genome bisulfite sequencing and microarrays.

With their expertise and validated methods, Eurofins Genomics ensures accurate and reliable biomarker validation for various applications. Whether you choose NGS or microarrays for your biomarker discovery project, Eurofins Genomics has the expertise and technology to guide you through the process and deliver informed results. Sign up for their newsletter to stay updated on the latest advancements in biomarker research